News

Legacy Pharmaceutical Packaging, which presently has 120 employees at its 90,000sqft plant in Earth City, intends to recruit 30 workers to staff the lines, and is funding the

Eszopiclone, marketed by Sepracor under the brand-name Lunesta, is a nonbenzodiazepine hypnotic agent (viz., a sedative) used as a treatment for insomnia. Eszopiclone is the active dextrorotatory stereoisomer

The granted claims of the patent, is valid until 2025, include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents and

Earlier, Trappsol Cyclo was approved under compassionate use by the FDA in April 2009, to treat Addi and Cassi Hempel, identical twin girls suffering from NPC disease. Reportedly,

GSK said that the main objectives of this project are to increase visual presence at-shelf, optimize shop-ability and create clear differentiation from competitors. Janice Jaworski, managing director of

The company said that the objective of the study was to evaluate the efficacy and safety of naproxcinod 375 mg bid and naproxcinod 750 mg bid compared with

PhytoMedical said that in addition to his appointment as president and CEO, Mr Lynch will also serve on the company’s board of directors. Mr Lynch brings over two

The investment is expected to enable Oval Medical to advance the development of its injection technology, including the production of new drug containers and prototype injection devices for

Microfluidics said that the industry and academic research teams are able to achieve superior nanoemulsions, nanosuspensions, nanoencapsulation and protein yield while minimizing quantities of limited and expensive materials